Brookstone Capital Management Sells 2,261 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brookstone Capital Management reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,327 shares of the pharmacy operator’s stock after selling 2,261 shares during the quarter. Brookstone Capital Management’s holdings in Walgreens Boots Alliance were worth $330,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. State Street Corp lifted its position in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 43.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC lifted its position in Walgreens Boots Alliance by 15.5% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after buying an additional 934,754 shares in the last quarter. Finally, FMR LLC lifted its position in Walgreens Boots Alliance by 2.5% during the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after buying an additional 80,525 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Down 3.2 %

Shares of WBA opened at $12.52 on Friday. The firm’s 50-day simple moving average is $9.57 and its 200 day simple moving average is $9.86. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $23.76. The firm has a market cap of $10.81 billion, a P/E ratio of -1.22, a price-to-earnings-growth ratio of 1.55 and a beta of 0.64. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter in the prior year, the business posted $0.66 EPS. The business’s revenue was up 7.6% compared to the same quarter last year. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.52 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.99%. Walgreens Boots Alliance’s payout ratio is presently -9.77%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on WBA. Royal Bank of Canada boosted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday. Jefferies Financial Group lowered their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Finally, Truist Financial boosted their price objective on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the stock a “hold” rating in a research note on Thursday. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $13.27.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.